Does PALBOCICLIB Cause Haemoglobin decreased? 1,693 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,693 reports of Haemoglobin decreased have been filed in association with PALBOCICLIB (Ibrance). This represents 1.9% of all adverse event reports for PALBOCICLIB.
1,693
Reports of Haemoglobin decreased with PALBOCICLIB
1.9%
of all PALBOCICLIB reports
196
Deaths
479
Hospitalizations
How Dangerous Is Haemoglobin decreased From PALBOCICLIB?
Of the 1,693 reports, 196 (11.6%) resulted in death, 479 (28.3%) required hospitalization, and 34 (2.0%) were considered life-threatening.
Is Haemoglobin decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 1,693 reports have been filed with the FAERS database.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Haemoglobin decreased?
LENALIDOMIDE (4,031)
RUXOLITINIB (3,297)
ECULIZUMAB (3,028)
ADALIMUMAB (2,459)
CLOZAPINE (2,396)
RITUXIMAB (1,803)
APIXABAN (1,779)
NIRAPARIB (1,759)
METHOTREXATE (1,754)
RIBAVIRIN (1,753)
Which PALBOCICLIB Alternatives Have Lower Haemoglobin decreased Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID